A health economic model to assess the cost-effectiveness of PEG IFN α-2a and ribavirin in patients with mild chronic hepatitis C
Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection
Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis
Long-term follow-up of the hepatitis C HENCORE cohort
Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection
The burden of hepatitis C in England
Serum adiponectin in chronic hepatitis C and B
Twenty years of selective hepatitis B vaccination
Cellular and humoral immune response to a third generation hepatitis B vaccine